Introduction: AOD01 is a novel, fully human immunoglobulin (Ig) G1 neutralizing monoclonal antibody that was developed as a therapeutic against severe... Context: SARS-CoV-2 is a global public-health concern. Interventions to prevent infection are urgently needed. The anti-inflammatory and antiviral effects of neem... Tenalisib (RP6530), a dual phosphoinositide 3-kinase δ/γ inhibitor was evaluated in a phase I/Ib study for maximum tolerated dose (MTD),... Current treatment options offer only symptomatic pain relief for patients with osteoarthritis (OA). Thus, a need exists for effective treatment... In the event of a highly pathogenic influenza pandemic, the Indian subcontinent would need 1.2 billion doses of vaccine to... Rise of diphtheria cases in adults is a cause of concern worldwide. Pertussis is also now affecting adults. We assessed...
First-in-Human Study to Evaluate Safety, Tolerabil...
Neem (Azadirachta Indica A. Juss) Capsules for Pro...
Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3...
Efficacy of an Ayurvedic Formulation for Mild-to-m...
A pandemic influenza vaccine in India: from strain...
Diphtheria, Tetanus, and Pertussis Immunity in Ind...